Soros Fund Management’s Array Biopharma Inc ARRY Stock Holding History

Soros Fund Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-197,179	Closed	-$9.13M	–	208
2019 Q2	$9.13M	Buy	+197,179	New	+$5.54M	0.21%	67
2018 Q2	–	Sell	-526,500	Closed	-$8.59M	–	274
2018 Q1	$8.59M	Buy	+526,500	New	+$8.43M	0.14%	136

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Soros Fund Management's ARRY Position: Q3 2019 in Review

Soros Fund Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 197,179 shares — an estimated $9.13M sold.

Soros Fund Management first reported a position in ARRY in Q1 2018 and held it in 2 quarters. The position peaked at $9.13M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Soros Fund Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Soros Fund Management sold 197,179 Array Biopharma Inc shares in Q3 2019, an estimated $9.13M.
Soros Fund Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 2 quarters.
Soros Fund Management's Array Biopharma Inc position peaked at $9.13M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Soros Fund Management's 13F filing for Q3 2019, filed 14 Nov 2019.